References for YK140 Rat GLP-2 EIA Kit
弊社キットが使用された論文を紹介しております。皆様のご研究の参考にして頂ければ幸いです。なお、測定方法(対象検体など)につきましては、弊社は
責任を負いかねる場合もございますので、予めご了承くださいますようお願い申し上げます。
1. |
Effects of the soluble fibre
pectin on intestinal cell proliferation, fecal short chain fatty acid production
and microbial population.
Fukunaga T, Sasaki M, Araki Y,
Okamoto T, Yasuoka T, Tsujikawa T, Fujiyama Y, Bamba T.
(Abs)Digestion. 2003;67(1-2):42-9. |
2. | Correlation between plasma
glucagon-like peptide 2 levels and proliferative makers in small intestinal
injury in rats induced by methotrexate administration. Hirotani Y, Yamamoto K, Ikeda K, Arakawa Y, Li J, Kitamura K, Kurokawa N, Tanaka K. Biol Pharm Bull. 2006 Nov;29(11):2327-30. (Full) |
3. | Effects of Hachimi-jio-gan
(Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic
rats.
Hirotani Y, Ikeda T, Ikeda
K, Yamamoto K, Onda M, Arakawa Y, Li J, Kitamura K, Kurokawa N.
Yakugaku Zasshi. 2007 Sep;127(9):1509-13. (Full) |
4. | alpha-Lactalbumin
hydrolysate stimulates glucagon-like peptide-2 secretion and small intestinal
growth in suckling rats.
Izumi H, Ishizuka S,
Inafune A, Hira T, Ozawa K, Shimizu T, Takase M, Hara H.
J Nutr. 2009 Jul;139(7):1322-7. Epub 2009 Jun 3. (Full) |
5. | The delay in the
development of experimental colitis from isomaltosyloligosaccharides in rats is
dependent on the degree of polymerization.
Iwaya H, Lee JS, Yamagishi
S, Shinoki A, Lang W, Thawornkuno C, Kang HK, Kumagai Y, Suzuki S, Kitamura
S,Hara H, Okuyama M, Mori H, Kimura A, Ishizuka S
PLos One. 2012;7(11): e50685. doi: 10.1371/journal.pone.0050658. Epub 2012 Nov 29 (Full) |
6. | Dietary lipids and sweeteners
regulate glucagon-like peptide-2 secretion. Sato S, Hokari R, Kurihara C, Sato H, Narimatsu K, Hozumi H, Ueda T, Higashiyama M, Okada Y, Watanabe C, Shunsuke K, Tomita K, Kawaguchi A, Nagao S, Miura S. Am J Physiol Gastrointest Liver Physiol. 2013 Jan 31. [Epub ahead of print] (Full) |
7. | Contribution of dipeptidyl peptides
IV to the severity of dextran sulfate sodium-induced colitis in the early
phase. Iwaya H. et al., Biosci. Biotechnol. Biochem., 77 (7), 1461-1466, 2013 (Full) |
8. | Tumor Necrosis Factor α Decreases Glucagon-Like Peptide-2 Expression by Up-Regulating G-Protein-Coupled Receptor 120 in Crohn Disease.
Tsukahara T, Watanabe K, Watanabe T, Yamagami H, Sogawa M, Tanigawa T, Shiba M, Tominaga K, Fujiwara Y, Maeda K, Hirakawa K, Arakawa T.
Am J Pathol. 2015 Jan;185(1):185-96. doi: 10.1016/j.ajpath.2014.09.010. Epub 2014 Nov 5.(Full) |
9. |
The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.
Yamazaki K, Yasuda N, Inoue T, Nagakura T, Kira K, Saeki T, Tanaka I.
Eur J Pharmacol. 2004 Mar 19;488(1-3):213-8. (Abs) |